The study of antiproliferation agent paclitaxel on preventing graft arterioscleriosis

Fudan University Journal of Medical Sciences

Volumn 33, Issue 2, 2006, Pages 225-228

  Yang, Zhao Hua ^a   Hong, Tao ^a   Wang, Chun Sheng ^a   Song, Kai ^a   Zheng, Jia Yu ^a   Zhu, Shi Jie ^a   Liu, Chen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Aorta transplantation; Graft arteriosclerosis; Paclitaxel

Indexed keywords

EID: 34248519206     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Mitchell RN. Allograft arteriopathy pathogensis update[J]. Cardiovascular Pathology, 2004, 13:33
2. McLaren AJ, Fuggle SV, Welsh KI, et al. Chronic allograft failure in human renal transplant-ation: a multivariate risk factor analysis[J]. Ann Surg, 2000, 232: 98
3. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and manage-ment[J]. J Heart Lung Transplant,2004,23:187
4. Yasuda S, Noguchi T, Gohda M, et al. Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model[J]. Cardiovascular Research, 2002,53:481
5. Hoffmann R, Langerberg R, Radke P, et al. Treatment of instent restenosis using a stent with non-polymer-based paclitaxel elution[J]. Am J Cardiol, 2004,93:760
6. Mennander A.Tiisala S, Halttunen J, et al. Chronic rejection in rat aortic allografts. A experimental model for transplant arteriosclerosis[J]. Art Thromb, 1991,11:671
7. Stefan T, Marcus N S, Christian G, et al. The antineoplastic drug paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplantation[J]. Transplantation, 2002,73:216